CRISPR Therapeutics

lyfgenia-or-casgevy-for-sickle-cell-disease-treatment

Dec 15, 2023

Lyfgenia or Casgevy: Who Will Lead the Sickle Cell Disease Treatment Space?

cell-and-gene-therapies-for-diabetes-treatment

May 01, 2023

Cell and Gene Therapies for Diabetes Treatment: A Permanent Cure for Patients?

vertex-crispr-gene-editing-therapy-exa-cel

Apr 14, 2023

Vertex/CRISPR’s Gene-editing Therapy exa-cel: Inch Ahead of Rival

Pharma News and Updates for Cingulate, Merck, Transcenta, Ipsen, Nuance

Apr 11, 2023

Ipsen’s Cabometyx Rejected by NICE; Vertex and CRISPR Therapeutics’s Submit BLA to the FDA for exa-cel; Orphan Drug Designation to Osemitamab for Pancreatic Cancer; FDA Clears Keytruda/Padcev for Bladder and Urothelial Cancer; Cingulate Completes Trial of CTx-1301 for ADHD; Nuance Pharma Announces Dosing of First Patient in ENHANCE Trial

CRISPR

Feb 26, 2019

Notizia

CRISPR

Feb 20, 2019

CRISPR proves to be a blessing for LASSA fever

BioGen

Feb 14, 2018

Business Cocktail

transthyretin amyloidosis

Jan 09, 2018

Notizia

Toll-like Receptors Agonist
TLR 7 and 8 Agonist
Gene Therapies Whitepaper
Toll-like Receptors Agonist
TLR 7 and 8 Agonist
Gene Therapies Whitepaper

Newsletter/Whitepaper